Timeline of EU action

Once adopted, the package of a total of €1.8 trillionwill help rebuild a post-COVID-19 Europe. It will be greener, more digital, more resilient and better fit for the current and forthcoming challenges. 651,000 doses of BioNTech and Pfizer vaccine, funded by the European Commission, will be shared with the Western Balkans with the facilitation of Austria.

The Commission introduced a measure to speed up the authorisation of adapted COVID-19 vaccines. This should allow companies to focus on gathering the necessary evidence in time and enable the authorisation of adapted vaccines with a smaller set of additional data submitted to the European Medicines Agency. The European Commission has disbursed €14.137 billion to 12 EU Member States in the seventh instalment of financial support under the SURE instrument. With this SURE disbursement, the EU has provided nearly €90 billion in back-to-back loans. Since the outbreak of COVID-19 in early 2020, the EU, EU Member States and European financial institutions, as Team Europe, have disbursed €34 billion in support to partner countries in addressing the pandemic and its consequences. This disbursement already exceeds by far the initial €20 billion Team Europe support package pledged in spring 2020, which has now increased to €46 billion.

• — The software stock tumbled 4% after ServiceNow released its latest quarterly figures.
• The Commission proposed immediate action to prepare Europe for the increased threat of coronavirus variants, including through the new European bio-defence preparedness plan called“HERA Incubator” .
• The Commission will support 23 new research projects with EUR 128 million under Horizon 2020, the EU’s research and innovation programme.
• This was a dual-tranche transaction, consisting of a €9 billion 5-year bond due on 6 July 2026 and a €6 billion 30-year bond due on 6 July 2051.
• For 2022, it expects the Covid vaccine to have brought in $34 billion, up by $2 billion from its prior outlook.

Shares tumbled on Jan. 4 after a Bank of America Securities analyst downgraded shares of Pfizer . He expects overall sales to tumble $32 billion this year, bigger than the $23 billion decline called for by FactSet-polled analysts. A Wells Fargo analyst downgraded shares on Jan. 17, saying Pfizer needs a „Covid reset.“ Both downgrades came after the Food and Drug Administration authorized Pfizer’s BioNTech -partnered booster shot for children under age 5. — Shares of the casino operator gained more than 4% after Las Vegas Sands released its latest quarterly results. However, the company’s adjusted property EBITDA of $329 million beat a StreetAccount forecast of $319 million.

Nasdaq rises after strong GDP report, Tesla jumps 8%

It consisted of a new 7-year bond of €5 billion due on 4 December 2029 and a €3 billion tap of an existing 20-year bond due on 4 July 2041. The Commission issued €11 billion in a dual tranche transaction, the proceeds of which will be used to support Ukraine under the EU’s MFA programme and Europe’s recovery under the flagship NextGenerationEU programme. The deal consisted of a €5 billion tap of the 7-year bond due on 4 December 2029 and a new 20-year bond of €6 billion due on 4 November 2042. Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is implementing many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured.

In terms of Covid itself, the effect of having first mover advantage has partially worn off but Pfizer also has an impressively broad portfolio of other drugs both in production and development. With an employee count approaching 80,000 and research facilities operational worldwide, much of Pfizer’s focus is on establishing a conveyor belt of new medicines in the marketplace. The company has adapted its original Covid vaccine to include an element targeting newer sub-variants of omicron dubbed BA.4 and BA.5. As the only company with a Covid shot and treatment, Pfizer stock is closely tied to the pandemic.

Pfizer expands commitment to ‘An Accord for a Healthier World’ to meet unmet medical needs in 45 lower-income countries

The company is expecting EPS of $7.95 to $8.65 for the year, behind a FactSet estimate of $10.12. Shares shed more than 7% after the paint maker offered a dismal outlook for the year as the housing market faces a slowdown. Airline earnings also rolled out, with Southwest falling 5% on a larger-than-expected loss fueled by its holiday meltdown. The Nasdaq Composite rose Thursday as traders combed through the latest batch of corporate earnings and fourth-quarter gross domestic product that came in above expectations.

„Nevertheless, with resilient consumer spending, low unemployment claims, and receding inflation, some of the clouds that were forming over the economy several months ago are beginning to clear.“ Thursday’s GDP data adds to a broadening picture of economic growth in the fourth quarter, according to Curt Long, chief economist at the National Association of Federally-Insured Credit Unions. As the outbreak of the novel coronavirus intensifies, the EU Civil Protection Mechanism has been activated following a request for assistance from France to provide consular support to EU citizens in Wuhan, China. To boost global preparedness, prevention and containment of the virus the Commission announced a new aid package worth €232 million. The Commission has also stepped up its support to Member States in the context of the work on preparedness, contingency and response planning. President von der Leyen established a coronavirus response team at political level to coordinate our response to the pandemic, bringing together all strands of action – from medical, to economic, to mobility and transport.

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Everyone ages 5 and older can receive a free Pfizer-BioNTech COVID-19 vaccine, even if they don’t have health insurance and regardless of their immigration status. Judged on its share price as of May 10, 2021, Pfizer has a market cap value of $220 billion. Its maternal vaccine was also 81.8% effective in the first 90 days of a newborn’s life. Last month, Pfizer said its experimental multiple myeloma drug led to a 61% response rate in patients with relapsed cancer or cancer that didn’t respond to other treatments. First, the authorizations were based on laboratory studies and human test data from an earlier iteration of the omicron-blocking booster.

As of 17 April, the EU has managed in an unprecedented repatriation effort to bring home over half a million of its citizens who were affected by coronavirus travel restrictions across the world. At the beginning of the outbreak, around 600,000 EU citizens declared themselves stranded outside the EU. Following requests for assistance via the EU Civil Protection Mechanism in the fight against the coronavirus pandemic, the EU is coordinating and co-financing the delivery of aid shipments in the EU and in neighbouring countries.

The Commission raised a further €10 billion in NextGenerationEU funds through its second bond syndication of 2022. The 10-year bond, due on 06 July 2032, brings the total financing raised under the programme forex market hours to €91 billion. This placement will continue to support Europe’s economic recovery under the Recovery and Resilience Facility and the other EU-budget programmes funded through NextGenerationEU.

Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On

The Commission disbursed €289 million to Lithuania in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help to kick-start the implementation of the crucial investment and reform measures outlined in Lithuania’s recovery and resilience plan. The Commission disbursed €5.1 billion to France in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help to kick-start the implementation of the crucial investment and reform measures outlined in France’s recovery and resilience plan.

The Commission called for a coordinated approach to the prolongation, as action at the external borders can only be effective if implemented by all EU and Schengen States at all borders, with the same end date and in a uniform manner. The measures will increase the cash flow of farmers and reduce the administrative burden both for national and regional authorities and for farmers in these particularly challenging times. Eight large-scale research projects, aimed at developing treatments and diagnostics for the coronavirus, were selected in a fast-track call for proposals, launched in March by the Innovative Medicines Initiative, a public-private partnership. The Luxembourg Stock Exchange marked the listing of the first social bond issued under the EU SURE programme. The EU established SURE earlier this year to help protect jobs and workers across Europe, which have been heavily impacted by the COVID-19 pandemic. The Commission mobilised €123 million from Horizon Europe, the EU research and innovation programme, for urgent research into coronavirus variants.

The Commission adopted a positive assessment of Slovakia’s recovery and resilience plan. This is an important step towards the EU disbursing €6.3 billion in grants under the Recovery and Resilience Facility. This financing will support the implementation of the crucial investment and reform measures outlined in Slovakia’s recovery and resilience plan. It will play a key role in enabling Slovakia emerge stronger from the COVID-19 pandemic. This is a key step paving the way for the EU to disburse €3.3 billion in grants to Sweden under the Recovery and Resilience Facility.

iShares $ Short Duration Corp Bond UCITS

The Commission has also unveiled its adjusted Work Programme for 2020, which will prioritise the actions needed to propel Europe’s recovery and resilience. On the occasion of the Global Vaccine Summit, the Commission announced a pledge of €300 million to Gavi, the Vaccine Alliance, for the period 2021–2025. It will help immunise 300 million children around the world and finance vaccine stockpiles to shield against outbreaks of infectious diseases.

This is an important step towards the EU disbursing €93 million in grants under the Recovery and Resilience Facility, that will support the implementation of the investment and reform measures outlined in Luxembourg’s recovery and resilience plan. The Commission adopted a positive assessment of Ireland’s recovery and resilience plan. This is an important step towards the EU disbursing €989 million in grants under the Recovery and Resilience Facility, that will support the implementation of the crucial investment and reform measures outlined in Ireland’s recovery and resilience plan. The Commission approved its seventh Advanced Purchase Agreement with a pharmaceutical company to ensure access to a potential vaccine against COVID-19 in Q4 of 2021 and in 2022. Under this contract, Member States will be able to purchase up to 100 million doses of the Novavax vaccine, with an option for 100 million additional doses over the course of 2021, 2022, and 2023, once reviewed and approved by EMA as safe and effective. The Commission adopted a positive assessment of Estonia’s recovery and resilience plan.

Financials Pfizer Inc.(PFE)

This payment will help to kick-start the implementation of the crucial investment and reform measures outlined in Luxembourg’s recovery and resilience plan. The Commission disbursed €9 billion to Spain in pre-financing, equivalent to 13% of the country’s financial allocation under the Recovery and Resilience Facility. The pre-financing payment will help to kick-start the implementation of the crucial investment and reform measures outlined in Spain’s recovery and resilience plan.

The Commission’s guidelines to Member States focus on the rational supply, allocation and use of vital medicines to treat coronavirus patients as well as medicines which may be at risk of shortage. The proposed actions should allow for a more coordinated approach across the EU, preserving the integrity of the Single Market whilst protecting public health. As part of the EU’s global response to the coronavirus outbreak, the EU – through its Emergency Trust Fund for Africa – has adopted anew assistance packageto protect migrants, stabilise local communities and respond to COVID-19 in North Africa. This package includes €80 million in new funds as well as €30 million reallocated from non-contracted actions under the EUTF. The EU will provide €24 million in humanitarian assistance for the most vulnerable people in Uganda in 2020, with a special focus on refugees and their host communities.

In addition, a second medical reserve will be hosted by Germany – already a rescEU host country. In total, there are now nine countries hosting the common European stockpiles of medical equipment. This common European stock of lifesaving medical equipment is distributed across Europe at times of medical emergencies, for example when national health systems are overwhelmed by coronavirus patients. The European Commission disbursed €14 billion to nine Member States in the fourth instalment of financial support to Member States under the SURE instrument. Belgium has received €2 billion, Cyprus €229 million, Hungary €304 million, Latvia €72 million, Poland €4.28 billion, Slovenia €913 million, Spain €1.03 billion, Greece €728 million and Italy €4.45 billion. These loans will assist Member States in addressing sudden increases in public expenditure to preserve employment.

The first delivery to all the partners in the region is due in May, with regular tranches to continue until August. European Commission President Ursula von der Leyen and US President Joe Biden have announced a new EU-US partnership to help vaccinate the world. The aim is to reach a 70% global vaccination rate by the time of the UN General Assembly 2022.

Pfizer Stock Fundamentals: Earnings Strong

This is an important step towards the EU to disbursing €68.9 billion in grants and €122.6 billion in loans under the Recovery and Resilience Facility. It will play a key role in enabling Italy to emerge stronger from the COVID-19 pandemic. This is an important step towards the EU disbursing €39.4 billion in grants under the Recovery and Resilience axitrader forex broker: introduction Facility, and will play a key role in enabling France emerge stronger from the COVID-19 pandemic. The Commission adopted a positive assessment of Slovenia’s recovery and resilience plan, a key step paving the way for the EU to disburse €1.8 billion in grants and €705 million in loans under the Recovery and Resilience Facility.

The first repatriations by air from France and Germany, co-financed by the EU Civil Protection Mechanism, brought home 447 European citizens, from Wuhan. The European Commission works on all fronts to support efforts to fight the coronavirus, helping Member States to repatriate their citizens and providing emergency services to China. The Commission co-financed the delivery of more than 25 tonnes of personal protective equipment to China after the EU Civil Protection Mechanism was activated.

The buyback program will become effective on April 1, with no set expiration date, according to a press release. Adjusted earnings came in at $1.19 per share, above the $1.13 expected by analysts polled by Refinitiv. And Tesla reported revenue at $24.32 billion, above the Refinitiv consensus estimate of $24.16 billion. Tesla stock gained more than 4% after beating analyst expectations for revenue and per-share earnings.

Pfizer stock is pulling back this month as analysts watch an expected pitfall this year from the company’s Covid vaccine and antiviral pill. Money Flow Uptick/Downtick RatioMoney flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an „uptick“ in price and the value of trades made on a „downtick“ in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. According to an industry report spectre.ai forex broker review from the drug analytics and contract research organization IQVIA Holdings , global expenditure on medicine is likely to reach $1.9 trillion by 2027, increasing in the range of 3% to 6% … But, according to some investment banks, those gains are now at risk as they fear the lagged effects of monetary tightening are likely to hit earnings and cause compression in profit margins this year. Investors looking for entry into these stocks may find them unpalatable at current valuations.

— The software stock tumbled 4% after ServiceNow released its latest quarterly figures. ServiceNow posted earnings per share of $2.28, beating a Refinitiv forecast of $2.02 per share. ’s fourth quarter, which saw earnings match expectations while revenues beat estimates.

In addition, the EU has also channelled €1 million to aid organisations in Uganda to support the coronavirus preparedness and control measures, in line with the national response plan. The European Commission launched a call for expressions of interest for thematic partnerships to pilot interregional innovation projects that support the response and recovery following the coronavirus pandemic. The aim of the call is to help regions grasp the opportunities emerging from the crisis, develop resilience and build on green and digital transformation for the recovery of the most affected sectors, such as health and tourism. The Commission will support 23 new research projects with EUR 128 million under Horizon 2020, the EU’s research and innovation programme. These research actions complement earlier efforts to develop diagnostics, treatments and vaccines, and are the result of the second emergency request for expressions of interest, launched by the Commission on 19 May. A second contract with a pharmaceutical company entered into force on 18 September following the contract’s formal signature between Sanofi-GSK and the Commission.